The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma

The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma

Insights into the biology of advanced renal cell carcinoma (aRCC) and the development of agents targeting the vascular endothelial growth factor (VEGF) pathway have positively impacted the outcomes for patients with aRCC. With the recent approval of the dual immune checkpoint inhibitors (ICIs), nivo...

Full description

Bibliographic Details
Main Authors: Asim Amin, Hans Hammers
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Immunology
Subjects:
combination immunotherapy
VEGF inhibition
immune check point inhibitor
advanced renal cell carcinoma
immuno modulation
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.03120/full

Similar Items

Similar Items